[Comprehensive organoprotection in patients with high cardiovascular risk: the possibility of ramipril from positions of evidence-based medicine].

Autor: Gaĭsenok OV; Research Center for Preventive Medicine, Petroverigsky per. 10, 101990 Moscow, Russia., Marcevich SIu, Belolipetskaia VG
Jazyk: ruština
Zdroj: Kardiologiia [Kardiologiia] 2013; Vol. 53 (9), pp. 90-4.
Abstrakt: Ramipril - a drug with a large evidence base. Various aspects of choosing a drug in cardiology from the standpoint of evidence-based medicine are risen from his example.
Databáze: MEDLINE